Catalase: a pivotal regulator of vascular disease
过氧化氢酶:血管疾病的关键调节因子
基本信息
- 批准号:8935386
- 负责人:
- 金额:$ 33.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-13 至
- 项目状态:未结题
- 来源:
- 关键词:AbdomenAbdominal Aortic AneurysmAneurysmAortaBiologicalBiological MarkersBiological ProcessBiomechanicsBlood VesselsCause of DeathCell Culture TechniquesCellsComplexDataDiseaseDown-RegulationDrug Delivery SystemsEnzymesExtracellular MatrixFundingGenerationsGenesGenetic PolymorphismGoalsHumanHydrogen PeroxideInflammationKnowledgeMechanicsMediatingMediator of activation proteinPathologyPatientsPhenotypePolymersProcessPromoter RegionsPropertyReactive Oxygen SpeciesRegulationRoleSignal PathwaySignal TransductionSingle Nucleotide PolymorphismStructureSystemTestingTherapeuticTherapeutic AgentsTherapeutic Use StudyTimeTissuesTranscriptional RegulationTransgenic MiceUnited StatesVariantVascular DiseasesWorkarterial stiffnessbasecardiovascular disorder riskcatalasecohortinsightmouse modelnovelnovel therapeuticsoverexpressionpreventpromotersmall moleculetherapeutic target
项目摘要
PROJECT SUMMARY
The formation of an abdominal aortic aneurysm is a complex biological and mechanical process that has as a
central feature the biological processes that result in a dysregulation of reactive oxygen species (ROS) in the
arterial wall. This is reflected in structural changes in the arterial wall that begin as relatively subtle changes in
extracellular matrix structure and function and ultimately proceed to cell loss. These structural changes in the
arterial wall are manifest as abnormalities in the mechanical properties of the vessel that eventually result in
the formation of aneurysms. Through the use of transgenic mouse models that overexpress catalase, we have
identified H2O2 as a pivotal mediator of abdominal aneurysm formation. The central goal of this proposal is to
better define the functional importance of the critical signaling pathways that govern H2O2 via regulation of
catalase expression as a platform for developing mechanism-targeted therapeutics for the treatment of
abdominal aortic aneurysms and for a better understanding of the variability in the disease process that occurs
in humans. In this proposal, we have three major goals. First, we would like to better understand the
regulation of catalase expression in the arterial wall at a much more mechanistic level as it pertains to changes
in arterial stiffness and abdominal aortic aneurysm formation. Second, we would like to take the knowledge
gained from our mechanistic studies and perform initial therapeutic studies using a novel biomechanical
delivery system that we have co-developed to prevent and treat abdominal aortic aneurysms. Finally, we will
extend these studies to humans and study the impact of differences in catalase expression that occur as the
result of a known functional polymorphism in the promoter region of the human catalase gene on arterial
biomechanics in a well characterized human cohort of subjects at risk for cardiovascular disease. Through
these studies, we hope to not only better understand how abdominal aortic aneurysms form, but also to gain
insights into therapeutic strategies and to perhaps develop a better understanding of disease variability in
humans.
项目摘要
腹主动脉瘤的形成是一个复杂的生物和机械过程,
核心特征是导致细胞中活性氧(ROS)调节异常的生物过程。
动脉壁这反映在动脉壁的结构变化中,这些结构变化开始为相对细微的变化,
细胞外基质的结构和功能,并最终进行细胞损失。这些结构性的变化
动脉壁的损伤表现为血管机械性能的异常,
动脉瘤的形成通过使用过表达过氧化氢酶的转基因小鼠模型,
确定H2O2作为腹主动脉瘤形成的关键介质。该提案的核心目标是
更好地定义通过调节H2O2的关键信号通路的功能重要性
过氧化氢酶表达作为开发用于治疗糖尿病的机制靶向治疗剂的平台
腹主动脉瘤和更好地了解发生的疾病过程中的变异性
在人类身上。在这项建议中,我们有三个主要目标。首先,我们希望更好地了解
在更机械的水平上调节动脉壁中的过氧化氢酶表达,
动脉硬化和腹主动脉瘤形成。第二,我们要把知识
从我们的机制研究中获得,并使用一种新的生物力学方法进行初步的治疗研究。
我们共同开发的用于预防和治疗腹主动脉瘤的输送系统。最后我们将
将这些研究扩展到人类,并研究过氧化氢酶表达差异的影响,
这是由于动脉粥样硬化斑块上人过氧化氢酶基因启动子区的已知功能多态性所致。
在具有心血管疾病风险的受试者的良好表征的人类队列中的生物力学。通过
通过这些研究,我们希望不仅能更好地了解腹主动脉瘤的形成,
深入了解治疗策略,并可能更好地了解疾病的变异性,
人类
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Robert Taylor其他文献
William Robert Taylor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Robert Taylor', 18)}}的其他基金
HOWARD UNIVERSITY GENERAL CLINICAL RESEARCH CENTER
霍华德大学普通临床研究中心
- 批准号:
8167000 - 财政年份:2010
- 资助金额:
$ 33.53万 - 项目类别:
Catalase: a pivotal regulator of vascular disease
过氧化氢酶:血管疾病的关键调节因子
- 批准号:
9271227 - 财政年份:2009
- 资助金额:
$ 33.53万 - 项目类别:
Catalase: a pivotal regulator of vascular disease
过氧化氢酶:血管疾病的关键调节因子
- 批准号:
9100846 - 财政年份:2009
- 资助金额:
$ 33.53万 - 项目类别:
Role of inflammatory cell RAGE in collateral vessel formation
炎症细胞RAGE在侧支血管形成中的作用
- 批准号:
7788446 - 财政年份:2009
- 资助金额:
$ 33.53万 - 项目类别:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
高血压、过氧化氢和血管炎症
- 批准号:
7899832 - 财政年份:2008
- 资助金额:
$ 33.53万 - 项目类别:
相似海外基金
Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
- 批准号:
23K08226 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
- 批准号:
10733477 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
Extracellular Vesicle Delivery System for Treatment of Abdominal Aortic Aneurysm
细胞外囊泡递送系统治疗腹主动脉瘤
- 批准号:
10751123 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
I-Corps: A Clinical Decision Support Tool to Manage Abdominal Aortic Aneurysm Patients
I-Corps:管理腹主动脉瘤患者的临床决策支持工具
- 批准号:
2318665 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
Standard Grant
Atherosclerosis drives arterial damage and abdominal aortic aneurysm formation and rupture
动脉粥样硬化导致动脉损伤和腹主动脉瘤形成和破裂
- 批准号:
483212 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
Operating Grants
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
PCSK9 抑制对腹主动脉瘤病理学和生长的影响
- 批准号:
10566800 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
开发基于磷脂的纳米疗法治疗腹主动脉瘤
- 批准号:
10749980 - 财政年份:2023
- 资助金额:
$ 33.53万 - 项目类别:
The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm
氨基酸饥饿反应激酶 GCN2 在腹主动脉瘤中的作用
- 批准号:
10584543 - 财政年份:2022
- 资助金额:
$ 33.53万 - 项目类别:
Atherosclerotic process drives arterial damage, abdominal aortic aneurysm formation, and rupture
动脉粥样硬化过程导致动脉损伤、腹主动脉瘤形成和破裂
- 批准号:
477264 - 财政年份:2022
- 资助金额:
$ 33.53万 - 项目类别:
Operating Grants
Endovascular Orifice Detection (EOrD) Device for in situ Fenestration of Abdominal Aortic Aneurysm
用于腹主动脉瘤原位开窗的血管内孔口检测 (EOrD) 装置
- 批准号:
10453104 - 财政年份:2022
- 资助金额:
$ 33.53万 - 项目类别: